Last reviewed · How we verify
adult acute myeloid leukemia with t 8 21 q22 q22 1 runx1 runx1t1
Approved treatments
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- adult acute myeloid leukemia with t 8 21 q22 q22 1 runx1 runx1t1 patent landscape — cliff calendar, originator estates, attackable patents
- adult acute myeloid leukemia with t 8 21 q22 q22 1 runx1 runx1t1 treatment landscape brief
- adult acute myeloid leukemia with t 8 21 q22 q22 1 runx1 runx1t1 treatment updates RSS
Related
- Treatment landscape: adult acute myeloid leukemia with t 8 21 q22 q22 1 runx1 runx1t1 patent cliff · adult acute myeloid leukemia with t 8 21 q22 q22 1 runx1 runx1t1 CI report
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing